VALN Stock Analysis: Buy, Sell, or Hold?

VALN - Valneva SE American Depositary Shares

Biological Products, (No Diagnostic Substances)
$5.58
-0.05 (-0.89%) β–Ό
5d: -11.99%
30d: +7.93%
90d: -49.13%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 13, 2026 0d

Get Alerted When VALN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: VALN is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$9.76
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$6.06
8.0% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.7x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: VALN is currently trading at $5.58, which is considered slightly low relative to its 30-day fair value range of $5.42 to $6.07. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.4) compared to its historical average (6.7). Remarkably, the market is currently pricing in an annual earnings decline of 6.9% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, VALN is in a strong downtrend. The price is currently testing key support at $5.55. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: VALN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.20 (+118.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $5.42 - $6.07
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 90.5%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 118.6% below Wall St target ($12.20)
  • WARNING: Recommendation downgraded due to -12.0% 5-day decline - wait for stabilization

Trading Range Analysis

30-Day Trading Range $5.42 - $6.07
Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $5.55
Resistance Level $6.73
Current Trend Strong Downtrend
Technical data as of Jun 3, 2026

Fundamental Context

Forward P/E (Next Year Est.) 5.37
Wall Street Target $12.20 (+118.6%)
Revenue Growth (YoY) -37.2%
Profit Margin -88.3%
Valuation Discount vs History -6.9% cheaper
PE vs Historical 5.4 vs 6.7 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -6.9% (market-implied from PE analysis)
1-Year Target $5.19 (-7%)
2-Year Target $4.84 (-13%)
3-Year Target $4.50 (-19%)
3-Yr Target (if PE normalizes) (PE: 5β†’7) $5.62 (+1%)
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.4 to 6.7
Stabilization Target: $6.97 (+24.9%)
PE Expansion Potential: +24.9%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 03, 2026 6:18 PM ET
Data refreshes hourly during market hours. Next update: 7:18 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for VALN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1023 53 HOLD
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$82 58 HOLD
ASND
Ascendis Pharma AS
STRONG BUY
16 analysts
$297 57 HOLD
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$9 48 HOLD
IMCR
Immunocore Holdings Ltd
STRONG BUY
17 analysts
$63 60 BUY

More Analysis for VALN

VALN Technical Chart VALN Price Prediction VALN Earnings Date VALN Investment Advisor VALN Fair Price Analyzer VALN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals